News
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...
4d
Zacks Investment Research on MSNAstraZeneca Boasts Strong Oncology Portfolio: Can It Sustain Growth?AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...
People are going on social media to share their belief that this antiparasitic drug can fight cancer. Learn what the science ...
10d
Health and Me on MSNDiabetes, Obesity And Cancer: Top 10 Drugs Of 2025 Are Changing How We Fight DiseaseFrom cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...
Successful drug development for people with cancers of the CNS has been challenging. There are multiple barriers to successful drug development including biological factors, rarity of the disease, and ...
Scientists have discovered how to turn molecules made by everyday toxic mold into highly effective cancer-fighting drugs.
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.
Today's health news covers generic cancer drugs failing quality tests, more evidence for ADHD meds' effectiveness, and more.
Cancer treatments include surgery, radiotherapy and drug treatments such as chemotherapy, hormone therapy or targeted cancer drugs. There are many different types of tests and scans. Find out about ...
PE eyes investments in oncology drug manufacturers: 6 deals Blackstone, HIG Capital and Nordic Capital are among the PE firms investing in the oncology drug market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results